🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Nog wachten op onder sterfte Geert?

Veel respect Luc!

“Kleine acties, grote impact?! Mijn lichtpunten in een donker jaar”. patientempowerment.be/getuigenissen/…

Fier en dankbaar bouwen aan de toekomst in ⁦AZ Delta⁩ samen met ⁦UGent⁩ olv ⁦PeterDeJaeger⁩ in samenwerking met ⁦Karl Dujardin⁩ ⁦@IDemedts⁩ ⁦Kim Denturck⁩ met dank aan ⁦VLAIO⁩ en Vlaams minister ⁦Hilde Crevits⁩ hln.be/roeselare/az-d…

Nog heel wat uitdagingen in de weg naar #waardetoevoegendezorg! Waaronder gestructureerde dataverzameling & de hoge nood aan erkenning van verpleegkundig specialisten! BEnurse BVVS Filip Baert AZ Delta

Clinical trials zijn sowieso belangrijk in hematologie omdat ze de genezingskansen kunnen verbeteren. Nu blijkt ook: Can Participation in Cancer Clinical Trials Save Money? ashclinicalnews.org/on-location/ot… The EBMT AZ Delta @LiekeSeynaeve Filip Baert

Peter Bossuyt from IBD kliniek Bonheiden presents in DOP081 the results of a feasibility study on semi-automated benchmarking of #quality outcome indicators in #IBD based on an eHealth.com application and automated data-extraction #ECCO2021 #ECCO21 AZ Delta @AZMMGent Filip Baert

Boosterprik van Pfizer/BioNTech verhoogt bescherming bij ouderen opmerkelijk (studie) mediplanet.be/nl/content/boo…?

OP01 #SPARE #edouardlouis CHU de Liège Exit-strategy study: IFX-IMM combo vs IFX mono vs IMM mono 🔑 points - infliximab withdrawal leads to more replapses - almost all recaptured response after re-induction - time in remission comparable GETAID Bird Group

📢 📢 The early BIRD fee for registration to the BIRD 2022 First Annual Congress ends on Friday 30th September! Read the program and register here bit.ly/3RVpa1f When: Friday 18th and Saturday 19th November Where: Kursaal Oostende

The Organizing Committee has decided to make registration to the BIRD 2022: First Annual Congress on Friday 18th and Saturday 19th November at Kursaal Oostende FREE for trainees who are BIRD members! Register here: bit.ly/3BiQYWB or scan the QR code below. See you there!

15 years after the first CESAME paper, the first ICARE paper is available! A unique European prospective cohort of more than 10,000 IBD patients exposed to all approved biologics. We did it! Thanks to all investigators and the GETAID team. More to come😊pubmed.ncbi.nlm.nih.gov/36152897/

Bird Group general assembly after a day of exciting 🇧🇪research and invited talks during the #bwge #IBD session.

Always a pleasure to interact with other scientific organizations. Peter Bossuyt explained the structure of Bird Group during the spring meeting of #nbvn. A structured model leads to high quality research and education even in small country like 🇧🇪 Gert Meeus

June’s paper of the month is "Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus" (Eur J Cancer, Volume 187, July 2023). Read here: birdgroup.be/en/papers/scie…

Fier op dit AZ Delta team 👏👇

“Europe as a network of city states, rather than a patchwork of nation states.” bigthink.com/strange-maps/t…

Selecting right meds can be challenging. We built app to help #IBD pts navigate treatments using conjoint analysis (IBDandMe.org)

In the Medscape studio with Filip Barry discussing biological therapy in Crohn’s disease. Great case/based discussion ... I will post link.